NEURODEGENERATIVE DISEASES Flashcards

1
Q

Disease

A

Alzheimer’s disease

Parkinson’s disease

Huntington’s disease

Amyotrophic lateral sclerosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What is the most common cause for dementia?

A

Alzheimer

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Alzheimer’s disease: epidemiology

A

6th leading cause of death
- 6.5M people with AD (1 in 9 over 65)
- Increase with age (primary risk factor)
- More common with women (2x)
- Number of people with AD is increasing

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Alzheimer’s disease: age of onset

A

Early Onset AD (familial)
Late Onset AD (sporadic)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Early Onset AD

A

Age of onset <65 yrs of age
- <5% of AD cases
- Familial
- Mendelian genetics: Autosomal dominant inheritance (only need one gene)
- 3 known genes (PSEN1, PSEN2, APP)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Late Onset AD

A

Age of onset >65 yrs of age
- >95% of AD cases
- Can be familial (mainly sporadic)
- Complex gentic with mutiple genetic risk factors (disease associated SNPs)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Alzheimer’s disease: risk factors

A

Age
Family History
Genetics (shared genes or environment)
- APOE
– E4 Increase Risk
– E2 Decrease Risk

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Alzheimer’s disease: health disparities

A

African American and Hispanic are more likely to get it

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Alzheimer’s disease: Clinical Symptoms

A

Progressive declines that are different than typical age-related changes
- Memory loss, Confusion about time or pace, Visual and spatial problems, Decreased or poor judgement, Social withdrawal, Changes in mood, personality and behavior

Most common cause of death is infections and damage in lungs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Alzheimer’s disease: gross anatomy

A
  • Decrease in overall brain weight
  • Cortical atrophy
  • Loss of pigmented neurons in the locus coeruleus
  • Areas preserved (Pigmented neurons in the substantia nigra, Occipital lobe, Cerebellum)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What happens in Cortical Atrophy

A

Cortex Shrinks
- Widening of sulcal spaces and narrowing of gyri
- Enlarged ventricles
- Degeneration in temporal, parietal, and frontal lobes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Where do the loss of pigmented neurons happen?

A

In locus coeruleus

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What areas gets perserved?

A
  • Pigmented neurons in the substantia nigra
  • Occipital lobe
  • Cerebellum
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Alzheimer’s disease: pathological hallmarks

A

Hallmarks required for diagnosis
- Amyloid plaques: aggregates of amyloid fibrils outside neurons, amyloid beta (Aβ)
- Neurofibrillary tangles: accumulation of hyperphosphorylated tau protein inside neurons, tau

Neuronal Loss:
- Glutamatergic pyramidal neurons in entorhinal cortex and hippocampus
- Cholinergic neurons in basal forebrain
- Noradrenergic neuron in locus coeruleus

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Amyloid plaques involves? and where?

A

It involves the aggregation of amyloid fibrils
- It happens outside neurons (amyloid beta)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Neurofibrillary tangles involves the accumulation of? and where

A

Involves the accumulation of hyperphosphorylated tau protein
- Happen INSIDE neurons, tau

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Which neuron in basal forebrain?

affected by neuronal loss

A

Cholinergic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Which neurons in locus coeruleus?

affected by neuronal loss

A

Noradrenergic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Which neurons in in entorhinal cortex and hippocampus?

affected by neuronal loss

A

Glutamatergic pyramidal neurons

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

What do acetylcholinesterase inhibitor do?

A

it inhibit ACH receptors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

When you get Late onset AD you develop?

A

Plaques, Tangles (Hallmarks) and your APOE gene mutate

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Movement Disorders

A

Hypokinetics Disorders
- Parkinson’s Disease

Hyperkinetic Disorders
- Huntington’s Disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Parkinson’s disease: epidemiology

A
  • Age of onset
    – Typically 60s-70s (~95%)
    – Early onset: before 50 (~5%)
  • 60000 new cases each year (1-2% of population above 65)
  • 1 M people in the US living with PD
  • More COMMON in men in the US
  • FASTEST growing neurological disease
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Parkinson’s disease: environmental risk factors

A

Increased risk of PD
- Exposure to specific types of pesticides and industrial toxicants
- Exposure to heavy metals
- Head injury

Decreased risk of PD
- Cigarette smoking
- Caffeine consumption
- Physical activity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

Do smoking increase or decrease your risk of Parkinson’s disease?

A

Decrease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

Parkinson’s disease: genetic risk factors

A

Familial PD
- SNCA (α-synuclein) ** **
– protein found in Lewy bodies, one of the pathological hallmarks of disease
- LRRK2 (Most common)
- GBA (Most common)

Sporadic PD
- SNCA (α-synuclein) ** **
- LRRK2 (Most common mutat)
- GBA (Most common)
- HLA genes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

Parkinson’s disease: medical risk factors

A

Constipation
REM sleep behavior disorder
Depression
Hyposmia
Excessive daytime sleepiness
Diabetes
High plasma urate (decreased risk)

28
Q

Parkinson’s disease: clinical symptoms

A

Cardinal motor symptoms: have two
- Bradykinesia (slow movement)
- Rigidity (stiffness)
- Tremor (at rest)
- Postural instability

Non-motor symptoms:
- Constipation
- RBD
- EDS
- Loss of sense of smell
- Mood disorders
- Sexual dysfunction

Difficult to diagnose;

29
Q

Parkinson’s disease: Pathological
hallmarks

A

Hallmarks required for diagnosis:
- Nigrostriatal degeneration: degeneration of pigmented dopaminergic neurons in
the nigrostriatal pathway
- Lewy bodies: aggregates of α-synuclein protein and other cellular components
inside neurons of the substantia

Extra-nigral and peripheral pathology:
- Lewy pathology in other regions of the central and peripheral nervous systems

30
Q

What is the degeneration of pigmented dopaminergic called?Where does it happen?

A

Nigrostriatal degeneration: Happen in the nigrostriatal pathway

31
Q

What is aggregates of α-synuclein protein called? Where does it happen?

A

Lewy bodies: Happens inside neurons in the substantia

32
Q

Parkinson’s disease: affected regions

A
  • Enteric nervous system
  • Olfactory bulb, brain stem
  • SN
  • Neocortex
33
Q

Parkinson’s disease: basal ganglia

A

Basal ganglia controls voluntary movement
- Output to motor cortex
- Motor cortex sends info to muscles via corticospinal tract

34
Q

What is Basal ganglia do?

A

Basal ganglia controls voluntary movement

35
Q

Parkinson’s disease: Current FDA- approved treatments

A

Deep brain stimulation (DBS): Surgery
Symptomatic (motor symptoms)
- Levidopa/carbidopa (most common
treatment)

36
Q

DA replacement

A

Levidopa/carbidopa: Precurser to dopamine

37
Q

Tremor is not specific to PD; what can indicate that it is PD?

A

Tremor at rest and L-DOPA responsive

38
Q

For PD; what treatment is most likely to help treat the motor symptoms?

A

L-Dopa

39
Q

Huntington’s disease: epidemiology

A
  • About 40,000 patients with HD in the US
  • Increasing worldwide 9-20% each decade
  • Not evenly distributed geographically (European is more affected)

Rare disease

40
Q

Huntington’s disease: genetics

A
  • Autosomal dominant inheritance
  • Independent of sex
41
Q

Huntington’s disease: genetics

A

CAG repeat expansion in Htt gene:
- Htt encodes huntingtin protein, a synaptic protein
- CAG encodes the amino acid glutamine
- Polyglutamine expansion in Huntingtin

Genetic Anticipation:
- Number of repeats increase with each generation (more copies = earlier onset)

42
Q

Huntingtin protein is encoded by?

A

Htt

43
Q

Huntington’s disease: clinical progression

A
  • Age of motor symptom onset: 30-50 (<20:5-10%)
  • Life expectancy after diagnosis: 15 years
  • Long prodromal phase: 10-15 years

Pneumonia is a common cause of death

44
Q

Huntington’s disease: clinical symptoms

A
  • Chorea: brief involuntary dance-like movements (Clinical Hallmark)
  • Difficulty with voluntary motor behavior
  • Motor impersistence
  • Impairments in fine motor activity
  • Variability of the pace of walking
45
Q

Is Chorea voluntary or involuntary?

A

involuntary dance-like movements

46
Q

Huntington’s disease: gross anatomy

A
  • Striatal (caudate) atrophy
  • Atrophy of basal ganglia and brain stem
  • Cortical thinning
  • Degeneration and reduced volume of cerebellum
  • Resulting enlargement of ventricles
47
Q

Huntington’s disease: pathological
hallmarks

A

HTT inclusions:
- Inclusions of mutant HTT protein found inside of neurons, intranuclear and cytoplasmic

Loss of GABAergic medium spiny neurons:
- Specific degeneration of MSNs in the striatum, the target of nigrostriatal DA neurons

48
Q

Where do the degeneration of MSN happen?

A

Striatum; Target of Nigrostriatal DA neurons

49
Q

What do GABA do?

A

Inhibit cortex; no control of motor neurons

50
Q

Huntington’s disease: treatments

A

Symptomatic (motor symptoms):
- Decrease DA signaling
- Medication that reduce movement as side effect

51
Q

What is the pattern of inheritance for the mutation in the Htt gene?

A

Autosomal dominant

52
Q

Typical age of onset for HD is younger/older than AD or PD

A

Younger: 30-50 yrs old

53
Q

What is the major pathological observation on gross examination in HD?

A

Striatal (caudate) atrophy

54
Q

Amyotrophic Lateral Sclerosis (ALS)

A

Amyotrophic: Muscle atrophy
Lateral Sclerosis: Hardening of the spinal cord lateral columns

55
Q

ALS: epidemiology

A
  • Age of onset: average 55
  • 32,000 people in the US living with ALS
    (450,000 worldwide)
  • Slightly more common in men
  • Most live 2 years after diagnosis
  • Earlier age of diagnosis => better prognosis
56
Q

ALS: Risk factors

A
  • Age
  • Sex
  • Family History (inherited dominantly)
  • Genetics: TARDBP(TDP-43)
57
Q

ALS: environmental risk factors

A

Risk factors
- Smoking

Protective Factors:
- Diet

58
Q

ALS: Clinical symptoms

A

Skeletal and muscle:
- Lower motor neuron signs
- Upper motor neuron signs

59
Q

Lower motor neuron signs

A

Spinal cord ==> Muscle
- Muscle weakness
- Muscle atrophy
- Fasciculations

60
Q

Upper motor neuron signs

A

Motor Cortex ==> Spinal Cord
- Overactive reflexes (Babinski, Hoffman)
- Spasticity
- Difficulty chewing/swallowing
- Psudobulbar effects
- Slurred and nasal speech

61
Q

ALS: pathology

A
  • Degeneration of UMNs
  • Sclerosis of the pyramidal tracts
  • Degeneration of LMNs in spinal cord
  • Muscle atrophy
62
Q

ALS: pathological hallmarks

A

Inclusions by appearance
- Ubiquitinated inclusions

Inclusions by protein
- TDP-43 (95% of sporadic ALS have it)

63
Q

ALS: FDA-approved treatments

A

Disease-modifying
Symptomatic
- Most just extent lifespan by 3-6 month
- Can’t take pills

64
Q

What disease has the fastest progression after diagnosis (from the 4)

A

ALS

65
Q

What 2 pathways degenerate in ALS?

A

Corticospinal and Corticalbulbar

66
Q

ALS is characerized by

A

Degeneration of upper and lower motor neurons.